Core-needle biopsy suffices in grading many mesenchymal neoplasms

Clinicians at Washington DC's Georgetown University Medical Center report that a core-needle biopsy is suitable for either bone or soft tissue and yields specimens that are conducive to histologic analysis.

In a study conducted at a care center specializing in orthopedic oncology, 141 patients with a suspected mesenchymal neoplasm underwent a percutaneous core-needle biopsy. Seventy-four percent of the biopsies were deemed accurate for both histologic features and tumor grade.

No infections resulted from the biopsy and none of the participants required a transfusion or other surgical management. Core-needle biopsy can effectively preclude the need for open biopsy in a majority of cases, the authors concluded.

To see the full text of this article, visit
www.rsnajnls.org
Page 1 of 240
Next Page